Trial Profile
An Open-Label, Single-Dose Study of the Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Sep 2019
Price :
$35
*
At a glance
- Drugs Lorcaserin (Primary)
- Indications Obesity
- Focus Pharmacokinetics
- Sponsors Arena Pharmaceuticals; Eisai Inc
- 29 Mar 2017 Results assessing pharmacokinetics and tolerability of Lorcaserin in different populations in three studies (NCT00828581, NCT00828438, and NCT00828932) published in the Clinical Therapeutics
- 31 Jan 2009 New trial record